BIOIMPEDANCE: NEW APPROACH TO NON-INVASIVE DETECTION OF LIVER FIBROSIS - A PILOT STUDY

Area of Science:

• Hepatology
• Medical Imaging
• Biophysics

Background:

• Liver fibrosis is a common complication of chronic hepatitis, often requiring invasive liver biopsy for assessment.
• Non-invasive screening tools for liver fibrosis are needed due to the limitations of liver biopsy.
• Bioimpedance analysis has emerged as a safe method for evaluating tissue fibrosis.

Purpose of the Study:

• To evaluate the effectiveness of monofrequential bipolar bioimpedance in detecting the severity of liver fibrosis.
• To assess its utility in patients with chronic viral hepatitis C infections.

Main Methods:

• A prospective study involving 110 patients, divided into a control group (n=50) and a chronic hepatitis C group (n=60).
• Bioimpedance measurements were performed using an Electro Sensor Complex.
• Receiver Operating Characteristic (ROC) curves were used to determine sensitivity and specificity.
• Patients with hepatitis C were further classified by fibrosis severity (Metavir scores F0-F1 vs. F3-F4).

Main Results:

• Bioimpedance analysis showed 85% sensitivity and 78% specificity in distinguishing between healthy individuals and those with hepatitis C (P=0.0001).
• Comparing minimal fibrosis (F0-F1) to advanced fibrosis/cirrhosis (F3-F4), bioimpedance demonstrated 85% sensitivity and 72% specificity (P=0.001, AUCROC=0.81).
• The delta value for conductance and neural network analysis of Electro Sensor Complex data were key metrics.

Conclusions:

• Bioimpedance technology offers good sensitivity and acceptable specificity for detecting liver fibrosis.
• This non-invasive approach shows potential for screening liver fibrosis in clinical settings.
• Further research may establish bioimpedance as a valuable tool in managing chronic liver diseases.